Visalytics
Visalytics
approved EB-2 (NIW)

Research Scientist

Biotechnologies · India · 2023-05-01

Processing Time
6 days
Decision Date
2023-05-01
Location
Texas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to define molecular mechanisms mediating chromatin regulation to discover novel nodes for the development of drugs that treat rhabdomyosarcomas and other cancers. This work focuses on understanding muscle cell functions as they relate to cancer to develop more effective and less invasive treatment approaches.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor of discovering novel drug nodes for rhabdomyosarcomas and other cancers was found to have both substantial merit and national importance.

2 Well-positioned to Advance the Endeavor Met

The petitioner's education, 341 citations, and record of success in biotechnology well-positioned him to advance his proposed research.

3 Waiver of Job Offer and Labor Certification Met

Based on a multifactorial assessment of the petitioner's expertise and the national importance of his cancer research, a waiver was deemed beneficial.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in life sciences, 8 peer-reviewed journal articles (2 first-authored), and 341 citations. Additionally, he completed 120 peer reviews for 4 journals and secured funding from the NIH, Wellcome Trust, and the Cancer Prevention & Research Institute of Texas, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Scientist

Biotechnology · Vietnam

WeGreened EB-2 (NIW) approved
Maryland 76 days 2022-04-16
The petitioner proposes to utilize her expertise in advanced molecular, chromosomal, and DNA tools to investigate the mechanisms of chromosomal rearrangement that drive cancer. Her work focuses on identifying novel therapies for aggressive forms of pediatric cancer, such as malignant rhabdoid tumors, and developing castrate-resistant prostate cancer lines to study molecular mechanisms of resistance.
View Case

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-05-01.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 6 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist